LABORATORY CORP OF AMERICA HOLDINGS - FORM 10-K - EX-32.2 - EXHIBIT 32.2 - February 28, 2020

Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - LABORATORY CORP OF AMERICA HOLDINGSlh10-kex3122019.htm
EX-31.1 - EXHIBIT 31.1 - LABORATORY CORP OF AMERICA HOLDINGSlh10-kex3112019.htm
EX-24.9 - EXHIBIT 24.9 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2492019.htm
EX-24.8 - EXHIBIT 24.8 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2482019.htm
EX-24.7 - EXHIBIT 24.7 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2472019.htm
EX-24.6 - EXHIBIT 24.6 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2462019.htm
EX-24.5 - EXHIBIT 24.5 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2452019.htm
EX-24.4 - EXHIBIT 24.4 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2442019.htm
EX-24.3 - EXHIBIT 24.3 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2432019.htm
EX-24.2 - EXHIBIT 24.2 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2422019.htm
EX-24.1 - EXHIBIT 24.1 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2412019.htm
EX-23.1 - EXHIBIT 23.1 - LABORATORY CORP OF AMERICA HOLDINGSexhibit2312019.htm
EX-21.1 - EXHIBIT 21.1 - LABORATORY CORP OF AMERICA HOLDINGSexhibit212019.htm
EX-3.2 - EXHIBIT 3.2 - LABORATORY CORP OF AMERICA HOLDINGSexhibit31amendedbylaws.htm
10-K - 10-K - LABORATORY CORP OF AMERICA HOLDINGSlh10-k2019.htm


Exhibit 32

Written Statement of
Chief Executive Officer and Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Laboratory Corporation of America Holdings (Company), each hereby certifies that, to his knowledge on the date hereof:

(a)  the Form 10-K of the Company for the Period Ended December 31, 2019, filed on the date hereof with the Securities and Exchange Commission (Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)  information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
By:
/s/ ADAM H. SCHECHTER
 
 
Adam H. Schechter
 
 
Chief Executive Officer
 
 
February 28, 2020

 
By:
/s/ GLENN A. EISENBERG
 
 
Glenn A. Eisenberg
 
 
Chief Financial Officer
 
 
February 28, 2020

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Laboratory Corporation of America Holdings and will be retained by Laboratory Corporation of America Holdings and furnished to the Securities and Exchange Commission or its staff upon request.


LABORATORY CORP OF AMERICA HOLDINGS Reports